Analyst stock forecast
Immunome Forecast: $36.00 Analyst Target
Direct answer
Immunome's average price target is $36.00.
The target implies +68.1% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +40.1%, the high target implies +86.8%, and the range spans 46.7% of the current price.
Forecast evidence checked September 26, 2026.
Get free Immunome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $21.41
- Average price target
- $36.00
- High price target
- $40.00
- Low price target
- $30.00
- Low target gap
- +40.1%
- Target upside
- +68.1%
- High target gap
- +86.8%
- Target range width
- 46.7%
- Consensus rating
- Strong Buy
- Analysts
- 14
- Evidence date
- September 26, 2026
- Valid through
- October 3, 2026
Explore related company data
Read the frequently asked questions.
What is Immunome's average price target?
Immunome's verified average price target is $36.00. The target range is $30.00 to $40.00.
How far are Immunome's low and high targets from the recorded price?
The low target implies +40.1%, while the high target implies +86.8%.
How many analysts are included in Immunome's consensus?
The verified consensus includes 14 analysts.
How is Immunome's target upside or downside calculated?
The average target of $36.00 is divided by the recorded price of $21.41, then one is subtracted to produce +68.1%. This does not guarantee a future return.
When was Immunome's analyst forecast verified?
The data was verified on 2026-09-26. The dataset is valid through 2026-10-03.